High Plasma Soluble CD163 During Infancy Is a Marker for Neurocognitive Outcomes in Early-Treated HIV-Infected Children.
Benki-Nugent, Sarah F
High Plasma Soluble CD163 During Infancy Is a Marker for Neurocognitive Outcomes in Early-Treated HIV-Infected Children. [electronic resource] - Journal of acquired immune deficiency syndromes (1999) 05 2019 - 102-109 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural
1944-7884
10.1097/QAI.0000000000001979 doi
Anti-HIV Agents--therapeutic use
Antigens, CD--blood
Antigens, Differentiation, Myelomonocytic--blood
Biomarkers--blood
Child
Child, Preschool
Female
HIV Infections--complications
Humans
Infant
Male
Neurodevelopmental Disorders--etiology
Neuropsychological Tests
Predictive Value of Tests
Proportional Hazards Models
Receptors, Cell Surface--blood
CD163 Antigen
High Plasma Soluble CD163 During Infancy Is a Marker for Neurocognitive Outcomes in Early-Treated HIV-Infected Children. [electronic resource] - Journal of acquired immune deficiency syndromes (1999) 05 2019 - 102-109 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural
1944-7884
10.1097/QAI.0000000000001979 doi
Anti-HIV Agents--therapeutic use
Antigens, CD--blood
Antigens, Differentiation, Myelomonocytic--blood
Biomarkers--blood
Child
Child, Preschool
Female
HIV Infections--complications
Humans
Infant
Male
Neurodevelopmental Disorders--etiology
Neuropsychological Tests
Predictive Value of Tests
Proportional Hazards Models
Receptors, Cell Surface--blood
CD163 Antigen